Latest market price
82.38
-0.32-0.39%
OverviewShort InterestFilings
DNTHQT56Dianthus Therapeutics, Inc.·NASDAQ
82.38-0.39%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 30, 2026SC 13GBeneficial ownership statement (passive)
Sep 18, 2026S-3ASRS-3ASR
Sep 18, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13GBeneficial ownership statement (passive)
Aug 11, 20264Statement of changes in beneficial ownership
Aug 11, 20264Statement of changes in beneficial ownership
Aug 11, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 07, 20264Statement of changes in beneficial ownership
Aug 04, 202610-QQuarterly report
Aug 04, 20268-KCurrent report
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 13, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 02, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
#1 / 25 of 187
Page
▼
/ 8